Yet another quiz*: EXAS’ ‘Deep-C’ study testing the Cologuard diagnostic for colorectal cancer has a patent-eligibility age range of 50-84 years; why are most of the patients enrolled to date near the lower bound of this range?
*Perhaps PGS should take the day off :- )
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”